Can You Take Fluoxetine with Mounjaro? What Prescribers Check

No well-documented direct pharmacokinetic interaction between fluoxetine and tirzepatide (Mounjaro) is currently identified in UK prescribing references — but your full medication history must still be reviewed by a prescriber before treatment begins.
Mounjaro slows gastric emptying, which can affect how quickly oral medicines (including antidepressants) are absorbed; this does not necessarily change their effectiveness but is worth flagging.
Both fluoxetine and GLP-1 medicines can independently influence appetite and mood; a prescriber will want to know your current mental-health picture before approving tirzepatide.
Always keep your GP informed when starting a new prescription medicine, at nume, GP notification is built into our process, in line with GPhC guidance.

Fluoxetine and Mounjaro (tirzepatide) are not known to have a direct pharmacokinetic interaction, and many people take antidepressants alongside weight-loss treatment. That said, combining any prescription medicines requires a prescriber to review your full medication list before tirzepatide is approved — this is a clinical decision, not a box-tick. The sections below explain what to watch for, what to tell your prescriber, and why the check matters even when the combination looks straightforward on paper. Mounjaro is a prescription-only medicine for weight management, and every prescription requires individual clinical assessment.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What you and your prescriber should consider when fluoxetine is already part of your routine

Is there a known interaction between fluoxetine and Mounjaro?

Based on current UK prescribing references, including the tirzepatide Summary of Product Characteristics published on the electronic Medicines Compendium, no direct clinically significant interaction between fluoxetine and tirzepatide has been identified. That is reassuring as a starting point. It does not, however, mean the combination is automatically appropriate for every individual.

What matters practically is the broader picture: how long you have been on fluoxetine, your current dose, how well it is managing your mood, and any other medicines you take alongside it. Tirzepatide is a dual GIP and GLP-1 receptor agonist that works partly by slowing gastric emptying. When the stomach empties more slowly, oral medicines can take longer to reach the small intestine where absorption happens. For fluoxetine (which is taken orally) this could, in theory, shift the timing of how it is absorbed. Real-world evidence for a meaningful clinical effect on fluoxetine specifically is limited, but it is one of the things a prescriber considers. The NHS patient information for tirzepatide advises people to tell their doctor or pharmacist about all medicines they are taking, for exactly this reason.

The short version: no red flag, but a conversation with a clinician is still necessary. Worth checking that your antidepressant dose has been stable for at least several weeks before starting any new treatment, that stability is useful information for your prescriber.

How do fluoxetine and tirzepatide affect appetite and mood separately?

Fluoxetine is a selective serotonin reuptake inhibitor. In some people it has appetite-suppressing effects, and weight change (either loss or gain depending on the individual and duration of treatment) is a recognised part of its profile. Tirzepatide works in a fundamentally different way: it activates gut hormone receptors that signal fullness to the brain, reducing hunger and slowing digestion. The two appetite-related mechanisms are distinct.

Because mood and appetite are connected, a prescriber will want to be confident that your mental health is stable and well-managed before adding tirzepatide. Significant uncontrolled depression or anxiety can complicate adherence to a new treatment and can also influence the physical symptoms some people notice during dose increases (things like nausea, fatigue, or changes in energy) in ways that are harder to interpret if mood is already fluctuating.

This is not a reason to assume the combination is unsuitable. Many people taking antidepressants have been assessed and prescribed tirzepatide without issue. It is a reason to be open about your mental health during the consultation. If you are wondering more broadly about your eligibility for Mounjaro, the eligibility page covers the full picture of what prescribers assess.

What should you tell your prescriber when both are in your routine?

Be specific. Rather than listing fluoxetine as a medicine you take, tell your prescriber the dose you are on and how long you have been taking it, and whether it was prescribed for depression, anxiety, OCD, or another indication. Also mention any other medicines or supplements in your routine. Some supplements interact with SSRIs, and a few interact with GLP-1 medicines too, and if you are wondering whether something like creatine fits into that picture, the page on taking creatine alongside Mounjaro is a good example of how those supplement-specific questions get worked through. If you are curious about a specific supplement, the page on NMN and Mounjaro is one example of how those questions get answered.

If your GP prescribed your fluoxetine, it is worth making sure they know you are starting tirzepatide. At nume, we notify your GP when we prescribe, which keeps everyone in the loop. That is not just a courtesy, it means your GP can flag anything relevant in your medical history that did not come up in the consultation, and it means your care stays joined up.

One practical habit: before your consultation, open your medicine cabinet and check the name and dose of every product you take regularly, including over-the-counter medicines, vitamins and supplements. Writing them down takes under a minute and makes the consultation significantly more thorough. Our prescribers ask about this during every assessment, it is easier when you have the list in front of you.

Does taking fluoxetine affect whether you meet Mounjaro's eligibility criteria?

Being prescribed an antidepressant does not automatically disqualify anyone from tirzepatide treatment. The licensed eligibility criteria for Mounjaro relate to BMI and weight-related health conditions: a BMI of 30 or above, or 27 or above alongside at least one condition such as hypertension, type 2 diabetes, dyslipidaemia, or obstructive sleep apnoea. The BMI eligibility guide explains these thresholds in detail.

What the prescriber is assessing is not just whether you meet the numbers but whether starting tirzepatide now is the right clinical decision for you specifically. Mental health status is one factor in that assessment, not because antidepressant users are excluded, but because prescribers take a whole-person view. If your depression or anxiety is actively unstable, a prescriber might suggest stabilising that first. If it is well-managed, as it is for many people on long-term fluoxetine, that is useful information that supports a straightforward assessment.

Our clinical team reviews consultations the same day they are submitted. If you want to understand how our process works, the about us page covers our clinical infrastructure, including our prescriber oversight. Questions about other health conditions and Mounjaro come up regularly, the page on Mounjaro and chronic kidney disease is one example of how condition-specific queries are handled. For a full view of available weight-loss treatments, the weight-loss treatments overview is a good place to start.

If you are ready to discuss your situation with a prescriber, you can speak to our prescribers through a free consultation, your full medication list, including fluoxetine, is part of what they review before anything is prescribed.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions